In a microarray-based gene expression study performed previously by our research team, we found that ECHDC3 mRNA expression was significantly increased within 2 h after an acute coronary syndrome, suggesting this gene could be a potential novel biomarker for the early stage of an acute episode [3]. Here, ECHDC3 is linked to acute coronary syndrome.